{
  "url": "https://openlegislation.uk/eu-regulation-2017-1224/introduction",
  "json_url": "https://openlegislation.uk/eu-regulation-2017-1224/introduction.json",
  "legislation": "eur/2017/1224",
  "legislation_title": "Commission Regulation (EU) 2017/1224 of 6 July 2017 amending Annex V to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2017-1224",
  "path": "introduction",
  "kind": "introduction",
  "number": null,
  "heading": "Introductory text",
  "text": "Commission Regulation (EU) 2017/1224\nof 6 July 2017\namending Annex V to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products\n(Text with EEA relevance)\nTHE EUROPEAN COMMISSION,\nHaving regard to the Treaty on the Functioning of the European Union,\nHaving regard to Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products, and in particular Article 31(1) thereof,\nWhereas:\n(1)\nThe substance 2-Methyl-2H-isothiazol-3-one, which has been assigned the name Methylisothiazolinone under the International Nomenclature of Cosmetic Ingredients (INCI), CAS number 2682-20-4, is currently authorised as a preservative in rinse-off cosmetic products at a concentration up to 0,01 % weight/weight (100 ppm) through entry 57 of Annex V to Regulation (EC) No 1223/2009.\n(2)\nThe Scientific Committee on Consumer Safety (SCCS) adopted an opinion on the safety of Methylisothiazolinone on 15 December 2015. The SCCS concluded that for rinse-off cosmetic products, a concentration up to 0,0015 % (15 ppm) Methylisothiazolinone is considered safe for the consumer from the point of view of induction of contact allergy.\n(3)\nIn light of that SCCS opinion, it is important to address the increased incidence of allergies induced by Methylisothiazolinone and that substance should therefore be further restricted in rinse-off products.\n(4)\nRegulation (EC) No 1223/2009 should therefore be amended accordingly.\n(5)\nThe industry should be allowed a reasonable period of time to make the necessary adjustments to product formulations in view of their placing on the market and for the withdrawal of non-compliant products from the market.\n(6)\nThe measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Cosmetic Products,\nHAS ADOPTED THIS REGULATION:",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "OJ L 342, 22.12.2009, p. 59."
    },
    {
      "type": "footnote",
      "label": "f2",
      "text": "SCCS/1557/15 (submission III)"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2017/1224/introduction",
    "retrieved_at": "2026-11-01T14:44:45.959344+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}